Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page shows a revision tag update from v3.6.3 to v3.6.4, indicating a new site version rather than a modification to the study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a revision update from v3.6.2 to v3.6.3, indicating a minor update to the page version. This reflects a small change to the page’s metadata or formatting without altering the study details.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new version of the page. This update does not modify the study details or visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedEnrollment status updated to No longer looking for participants, affecting recruitment visibility. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with an updated Intervention/Treatment heading and the Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.4%

- Check58 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5, reflecting a software version update on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.4 was applied to the page, replacing the previous v3.5.3; this is a metadata/version update and does not modify the study data or content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.